Literature DB >> 15473456

Gender differences among long-distance backpackers: A prospective study of women Appalachian Trail backpackers.

David R Boulware1.   

Abstract

OBJECTIVE: Backpacking is a popular recreational activity, yet the differential experiences of women are unknown. The objective was to compare women with men backpackers to determine the extent to which injuries and illnesses limit endurance outdoor recreational activities.
METHODS: This was a prospective cohort surveillance survey of 334 persons who hiked the Appalachian Trail for > or =7 days. At the end of their hike, 280 subjects completed a questionnaire. Male hikers served as controls for injury and illness.
RESULTS: Women comprised 26% (72 of 280) of the sample. The mean (+/-SD) duration of hiking was 144 +/- 66 days covering 1570 +/- 680 miles. Fifty-seven percent (41 of 72) of women and 72% (150 of 208) of men attained their goal (P = .02). The occurrence of individual musculoskeletal problems, such as strains, sprains, arthralgias, tendonitis, and fractures, were similar (P = .9) between sexes. The occurrence of diarrhea (56%) was also similar (relative risk [RR] 1.0; P = .9) between sexes. Of regularly menstruating women, 87% (43 of 49) had menstrual changes while hiking, such as change in frequency (45%) or character (43%) (RR 3.1; 95% CI, 2.0-4.8; P < .001). Shortened duration of menses was most common (41%). Amenorrhea occurred in 22% (11 of 49) of women, including 5 of 25 taking oral contraceptive pills (OCPs). Breakthrough, midcycle bleeding occurred in 20% (10 of 49) of women.
CONCLUSIONS: Women had similar experiences as compared with men when backpacking. Menstrual changes were very common including amenorrhea. Prolonged amenorrhea raises concern for potential bone mineral density loss, and OCPs should be considered to prevent such loss.

Entities:  

Mesh:

Year:  2004        PMID: 15473456      PMCID: PMC1946964          DOI: 10.1580/1080-6032(2004)15[175:gdalba]2.0.co;2

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  13 in total

1.  Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial.

Authors:  F Berrino; C Bellati; G Secreto; E Camerini; V Pala; S Panico; G Allegro; R Kaaks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-01       Impact factor: 4.254

Review 2.  Exercise-associated amenorrhea.

Authors:  C L Otis
Journal:  Clin Sports Med       Date:  1992-04       Impact factor: 2.182

3.  American Academy of Pediatrics: Committee on Sports Medicine: Amenorrhea in adolescent athletes.

Authors: 
Journal:  Pediatrics       Date:  1989-08       Impact factor: 7.124

4.  Androgen and estrogen dynamics: relationships with age, weight, and menopausal status.

Authors:  C Longcope; S Baker
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

5.  Bone density is compromised in amenorrheic women despite return of menses: a 2-year study.

Authors:  S Jonnavithula; M P Warren; R P Fox; M I Lazaro
Journal:  Obstet Gynecol       Date:  1993-05       Impact factor: 7.661

6.  The female athlete triad: disordered eating, amenorrhea, osteoporosis.

Authors:  K K Yeager; R Agostini; A Nattiv; B Drinkwater
Journal:  Med Sci Sports Exerc       Date:  1993-07       Impact factor: 5.411

7.  Bone density at multiple skeletal sites in amenorrheic athletes.

Authors:  M L Rencken; C H Chesnut; B L Drinkwater
Journal:  JAMA       Date:  1996-07-17       Impact factor: 56.272

8.  Bone mineral content of amenorrheic and eumenorrheic athletes.

Authors:  B L Drinkwater; K Nilson; C H Chesnut; W J Bremner; S Shainholtz; M B Southworth
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

9.  Gonadal steroids in athletic women contraception, complications and performance.

Authors:  J C Prior; Y Vigna
Journal:  Sports Med       Date:  1985 Jul-Aug       Impact factor: 11.136

10.  Bone mineral density after resumption of menses in amenorrheic athletes.

Authors:  B L Drinkwater; K Nilson; S Ott; C H Chesnut
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.